{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:48:50Z","timestamp":1763621330705,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10067-022-06466-8","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T15:03:41Z","timestamp":1670425421000},"page":"591-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effective therapy of pirfenidone in a patient with idiopathic retroperitoneal fibrosis: report of a case"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9547-887X","authenticated-orcid":false,"given":"Juan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-9141","authenticated-orcid":false,"given":"Zhuoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"6466_CR1","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1681\/ASN.2015101110","volume":"27","author":"A Vaglio","year":"2016","unstructured":"Vaglio A, Maritati F (2016) Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol 27:1880\u20131889. https:\/\/doi.org\/10.1681\/ASN.2015101110","journal-title":"J Am Soc Nephrol"},{"key":"6466_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/03009742.2018.1497700","volume":"48","author":"J Zhao","year":"2019","unstructured":"Zhao J, Li J, Zhang Z (2019) Long-term outcomes and predictors of a large cohort of idiopathic retroperitoneal fibrosis patients: a retrospective study. Scand J Rheumatol 48:239\u2013245. https:\/\/doi.org\/10.1080\/03009742.2018.1497700","journal-title":"Scand J Rheumatol"},{"key":"6466_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10067-010-1580-6","volume":"30","author":"K-P Li","year":"2011","unstructured":"Li K-P, Zhu J, Zhang J-L, Huang F (2011) Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol 30:601\u2013605. https:\/\/doi.org\/10.1007\/s10067-010-1580-6","journal-title":"Clin Rheumatol"},{"key":"6466_CR4","first-page":"251","volume":"13","author":"FA Al-Hammouri","year":"2019","unstructured":"Al-Hammouri FA, Khori FA, Abu Qamar AA et al (2019) Management of Idiopathic retroperitoneal fibrosis, a retrospective study at Prince Hussein Urology and Organ transplantation center (PHUO). Jordan Iran J Kidney Dis 13:251\u2013256","journal-title":"Jordan Iran J Kidney Dis"},{"key":"6466_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7326\/0003-4819-154-1-201101040-00005","volume":"154","author":"PJ Scheel Jr","year":"2011","unstructured":"Scheel PJ Jr, Feeley N, Sozio SM (2011) Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med 154:31\u201336. https:\/\/doi.org\/10.7326\/0003-4819-154-1-201101040-00005","journal-title":"Ann Intern Med"},{"key":"6466_CR6","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1136\/annrheumdis-2013-203267","volume":"72","author":"F Alberici","year":"2013","unstructured":"Alberici F, Palmisano A, Urban ML et al (2013) Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 72:1584\u20131586. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203267","journal-title":"Ann Rheum Dis"},{"key":"6466_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/annrheumdis-2019-216258","volume":"79","author":"ML Urban","year":"2020","unstructured":"Urban ML, Maritati F, Palmisano A et al (2020) Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients. Ann Rheum Dis 79:433\u2013434. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216258","journal-title":"Ann Rheum Dis"},{"key":"6466_CR8","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/ndt\/gfaa083","volume":"36","author":"V Raglianti","year":"2021","unstructured":"Raglianti V, Rossi GM, Vaglio A (2021) Idiopathic retroperitoneal fibrosis: an update for nephrologists. Nephrol Dial Transplant 36:1773\u20131781. https:\/\/doi.org\/10.1093\/ndt\/gfaa083","journal-title":"Nephrol Dial Transplant"},{"key":"6466_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","volume":"378","author":"A Vaglio","year":"2011","unstructured":"Vaglio A, Palmisano A, Alberici F et al (2011) Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 378:338\u2013346. https:\/\/doi.org\/10.1016\/S0140-6736(11)60934-3","journal-title":"Lancet"},{"key":"6466_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","volume":"8","author":"TM Maher","year":"2020","unstructured":"Maher TM, Corte TJ, Fischer A et al (2020) Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med 8:147\u2013157. https:\/\/doi.org\/10.1016\/S2213-2600(19)30341-8","journal-title":"Lancet Respir Med"},{"key":"6466_CR11","doi-asserted-by":"publisher","first-page":"01051","DOI":"10.1053\/j.ajkd.2021.03.027","volume":"S0272\u20136386","author":"M Ruiz-Ortega","year":"2022","unstructured":"Ruiz-Ortega M, Lamas S, Ortiz A (2022) Antifibrotic agents for the management of CKD: a review. Am J Kidney Dis S0272\u20136386:01051\u201301059. https:\/\/doi.org\/10.1053\/j.ajkd.2021.03.027","journal-title":"Am J Kidney Dis"},{"key":"6466_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708463","volume":"12","author":"L Deng","year":"2021","unstructured":"Deng L, Chen Y, Hu X, Zhou J, Zhang Y (2021) Case report: successful treatment of refractory interstitial lung disease with cyclosporine A and pirfenidone in a child with SLE. Front Immunol 12:708463. https:\/\/doi.org\/10.3389\/fimmu.2021.708463","journal-title":"Front Immunol"},{"key":"6466_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s13075-014-0510-4","volume":"16","author":"M Rodr\u00edguez-Castellanos","year":"2015","unstructured":"Rodr\u00edguez-Castellanos M, Tlacuilo-Parra A, S\u00e1nchez-Enr\u00edquez S, V\u00e9lez-G\u00f3mez E, Guevara-Guti\u00e9rrez E (2015) Pirfenidone gel in patients with localized scleroderma: a phase II study. Arthritis Res Ther 16:510. https:\/\/doi.org\/10.1186\/s13075-014-0510-4","journal-title":"Arthritis Res Ther"},{"key":"6466_CR14","doi-asserted-by":"publisher","first-page":"854314","DOI":"10.3389\/fcvm.2022.854314","volume":"9","author":"TCL Bracco Gartner","year":"2022","unstructured":"Bracco Gartner TCL, Crnko S, Leiteris L, van Adrichem I et al (2022) Pirfenidone has anti-fibrotic effects in a tissue-engineered model of human cardiac fibrosis. Front Cardiovasc Med 9:854314. https:\/\/doi.org\/10.3389\/fcvm.2022.854314","journal-title":"Front Cardiovasc Med"},{"key":"6466_CR15","doi-asserted-by":"publisher","unstructured":"Xi Y, Li Y, Xu P, Li S, Liu Z, Tung HC, Cai X, Wang J, Huang H, Wang M, Xu M, Ren S, Li S, Zhang M, Lee YJ,\u00a0Huang L, Yang D, He J, Huang Z, Xie W\u00a0(2021)\u00a0The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the\u00a0small oxidoreductase glutaredoxin-1. Sci Adv\u00a07(36):eabg9241.\u00a0https:\/\/doi.org\/10.1126\/sciadv.abg9241","DOI":"10.1126\/sciadv.abg9241"},{"key":"6466_CR16","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra1705751","volume":"378","author":"DJ Lederer","year":"2018","unstructured":"Lederer DJ, Martinez FJ (2018) Idiopathic pulmonary fibrosis. N Engl J Med 378:1811\u20131823. https:\/\/doi.org\/10.1056\/NEJMra1705751","journal-title":"N Engl J Med"},{"key":"6466_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","volume":"62","author":"SM Ruwanpura","year":"2020","unstructured":"Ruwanpura SM, Thomas BJ, Bardin PG (2020) Pirfenidone: molecular mechanisms and potential clinical applications in lung disease. Am J Respir Cell Mol Biol 62:413\u2013422. https:\/\/doi.org\/10.1165\/rcmb.2019-0328TR","journal-title":"Am J Respir Cell Mol Biol"},{"key":"6466_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/sj.ki.5002427","volume":"72","author":"D Corradi","year":"2007","unstructured":"Corradi D, Maestri R, Palmisano A et al (2007) Idiopathic retroperitoneal fibrosis: clinico-pathologic features and differential diagnosis. Kidney Int 72:742\u2013753. https:\/\/doi.org\/10.1038\/sj.ki.5002427","journal-title":"Kidney Int"},{"key":"6466_CR19","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1097\/pas.0b013e3181b72882","volume":"33","author":"Y Zen","year":"2009","unstructured":"Zen Y, Onodera M, Inoue D et al (2009) Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 33:1833\u20131839. https:\/\/doi.org\/10.1097\/pas.0b013e3181b72882","journal-title":"Am J Surg Pathol"},{"key":"6466_CR20","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/hep.21697","volume":"45","author":"Y Zen","year":"2007","unstructured":"Zen Y, Fujii T, Harada K et al (2007) Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45:1538\u20131546. https:\/\/doi.org\/10.1002\/hep.21697","journal-title":"Hepatology"},{"key":"6466_CR21","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/art.38032","volume":"65","author":"A Vaglio","year":"2013","unstructured":"Vaglio A, Catanoso MG, Spaggiari L et al (2013) Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum 65:2469\u20132475. https:\/\/doi.org\/10.1002\/art.38032","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06466-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T10:18:20Z","timestamp":1674555500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06466-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["6466"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06466-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}